Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comment on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis".
Péré H, Pavie J, Pernot S, Veyer D, Bertaud D, Hurel S, Bélec L, Hans S, Ménard M, Cochand-Priollet B, Weiss L, Bats AS, Badoual C; AP-HP CoMPap (Consultation Multidisciplinaire Papillomavirus) group. Péré H, et al. Among authors: belec l. Br J Cancer. 2019 Apr;120(9):952-953. doi: 10.1038/s41416-019-0439-0. Epub 2019 Mar 26. Br J Cancer. 2019. PMID: 30911088 Free PMC article. No abstract available.
Increased polymorphism in the HR-1 gp41 env gene encoding the enfuvirtide (T-20) target in HIV-1 variants harboring multiple antiretroviral drug resistance mutations in the pol gene.
Si-Mohamed A, Piketty C, Tisserand P, LeGoff J, Weiss L, Charpentier C, Kazatchkine MD, Bélec L. Si-Mohamed A, et al. Among authors: belec l. J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):1-5. doi: 10.1097/01.qai.0000243118.59906.f4. J Acquir Immune Defic Syndr. 2007. PMID: 17075396
Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic.
Charpentier C, Gody JC, Mbitikon O, Moussa S, Matta M, Péré H, Fournier J, Longo Jde D, Bélec L. Charpentier C, et al. Among authors: belec l. AIDS Res Hum Retroviruses. 2012 Jan;28(1):87-94. doi: 10.1089/aid.2011.0035. Epub 2011 Jun 20. AIDS Res Hum Retroviruses. 2012. PMID: 21599597
Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.
Péré H, Charpentier C, Mbelesso P, Dandy M, Matta M, Moussa S, De Dieu Longo J, Grésenguet G, Abraham B, Bélec L. Péré H, et al. Among authors: belec l. AIDS Res Hum Retroviruses. 2012 Apr;28(4):315-23. doi: 10.1089/aid.2011.0127. Epub 2011 Sep 23. AIDS Res Hum Retroviruses. 2012. PMID: 21942692 Clinical Trial.
425 results